|
1
|
Lee MR, Lin C, Lu CC, Kuo SC, Tsao JW,
Juan YN, Chiu HY, Lee FY, Yang JS and Tsai FJ: YC-1 induces G0/G1
phase arrest and mitochondria-dependent apoptosis in
cisplatin-resistant human oral cancer CAR cells. Biomedicine.
7:122017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang ZX, Bian HB, Yang JS, De W and Ji XH:
Adenovirus-mediated suicide gene therapy under the control of Cox-2
promoter for colorectal cancer. Cancer Biol Ther. 8:1480–1488.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferguson BL, Barber S, Asher IH and Wood
CR: Role of oral microbial infections in oral cancer. Dent Clin
North Am. 61:425–434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen S, Hu H, Miao S, Zheng J, Xie Z and
Zhao H: Anti-tumor effect of cisplatin in human oral squamous cell
carcinoma was enhanced by andrographolide via upregulation of
phospho-p53 in vitro and in vivo. Tumour Biol.
39:10104283177053302017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumari K, Haragannavar VC, Kumar KV,
Prasad K and Nambiar S: Basaloid Squamous Cell Carcinoma of Tongue:
A report with emphasis on immunohistochemistry. J Clin Diagn Res.
11:ZD16–ZD18. 2017.PubMed/NCBI
|
|
6
|
Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM,
Tsao JW, Juan YN, Chiu HY, Yang JS and Wang CC: Resveratrol-induced
autophagy and apoptosis in cisplatin-resistant human oral cancer
CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol.
50:873–882. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan CH, Horng CT, Lee CF, Chiang NN, Tsai
FJ, Lu CC, Chiang JH, Hsu YM, Yang JS and Chen FA: Epigallocatechin
gallate sensitizes cisplatin-resistant oral cancer CAR cell
apoptosis and autophagy through stimulating AKT/STAT3 pathway and
suppressing multidrug resistance 1 signaling. Environ Toxicol.
32:845–855. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang PY, Peng SF, Lee CY, Lu CC, Tsai SC,
Shieh TM, Wu TS, Tu MG, Chen MY and Yang JS: Curcumin-loaded
nanoparticles induce apoptotic cell death through regulation of the
function of MDR1 and reactive oxygen species in cisplatin-resistant
CAR human oral cancer cells. Int J Oncol. 43:1141–1150. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Zhang B, Jiang L, Zeng X, Chen Y,
Feng X, Guo Y and Chen Q: RACK1, an excellent predictor for poor
clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J
Cancer. 45:490–496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schoop RA, Noteborn MH and Baatenburg de
Jong RJ: A mouse model for oral squamous cell carcinoma. J Mol
Histol. 40:177–181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen SC, Chang PM and Yang MH:
Cisplatin/tegafur/uracil/irinotecan triple combination therapy for
recurrent/metastatic head and neck squamous cell carcinoma: A phase
I/II clinical study. Oncologist. 21:537–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Štulhofer Buzina D, Martinac I, Ledić
Drvar D, Čeović R, Bilić I and Marinović B: Adverse reaction to
cetuximab, an epidermal growth factor receptor inhibitor. Acta
Dermatovenerol Croat. 24:70–72. 2016.PubMed/NCBI
|
|
13
|
El-Deftar MF, El Gerzawi SM, Abdel-Azim AA
and Tohamy SM: Prognostic significance of ploidy and S-phase
fraction in primary intraoral squamous cell carcinoma and their
corresponding metastatic lymph nodes. J Egypt Natl Canc Inst.
24:7–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El-Naaj IA, Leiser Y, Shveis M, Sabo E and
Peled M: Incidence of oral cancer occult metastasis and survival of
T1-T2N0 oral cancer patients. J Oral Maxillofac Surg. 69:2674–2679.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee SY, Kim YJ, Chung SO and Park SU:
Recent studies on ursolic acid and its biological and
pharmacological activity. EXCLI J. 15:221–228. 2016.PubMed/NCBI
|
|
16
|
Kashyap D, Tuli HS and Sharma AK: Ursolic
acid (UA): A metabolite with promising therapeutic potential. Life
Sci. 146:201–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katashima CK, Silva VR, Gomes TL, Pichard
C and Pimentel GD: Ursolic acid and mechanisms of actions on
adipose and muscle tissue: A systematic review. Obes Rev.
18:700–711. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Woźniak Ł, Skapska S and Marszałek K:
Ursolic acid-a pentacyclic triterpenoid with a wide spectrum of
pharmacological activities. Molecules. 20:20614–20641. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Zhang Y, Dong L, Gao Q, Yin L,
Quan H, Chen R, Fu X and Lin D: Ethnopharmacology, phytochemistry,
and pharmacology of Cornus officinalis Sieb. et Zucc. J
Ethnopharmacol. 213:280–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Wei K, Xu J, Yang D, Zhang C,
Wang Z and Li M: Belamcanda chinensis (L.) DC-An
ethnopharmacological, phytochemical and pharmacological review. J
Ethnopharmacol. 186:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie C, Xie Z, Xu X and Yang D: Persimmon
(Diospyros kaki L.) leaves: A review on traditional uses,
phytochemistry and pharmacological properties. J Ethnopharmacol.
163:229–240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Novotný L, Vachálková A and Biggs D:
Ursolic acid: An anti-tumorigenic and chemopreventive activity.
Minireview. Neoplasma. 48:241–246. 2001.PubMed/NCBI
|
|
23
|
Lu CC, Huang BR, Liao PJ and Yen GC:
Ursolic acid triggers nonprogrammed death (necrosis) in human
glioblastoma multiforme DBTRG-05MG cells through MPT pore opening
and ATP decline. Mol Nutr Food Res. 58:2146–2156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shanmugam MK, Dai X, Kumar AP, Tan BK,
Sethi G and Bishayee A: Ursolic acid in cancer prevention and
treatment: Molecular targets, pharmacokinetics and clinical
studies. Biochem Pharmacol. 85:1579–1587. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuttan G, Pratheeshkumar P, Manu KA and
Kuttan R: Inhibition of tumor progression by naturally occurring
terpenoids. Pharm Biol. 49:995–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lernoux M, Schnekenburger M, Dicato M and
Diederich M: Anti-cancer effects of naturally derived compounds
targeting histone deacetylase 6-related pathways. Pharmacol Res.
129:337–356. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gosepath EM, Eckstein N, Hamacher A,
Servan K, von Jonquieres G, Lage H, Györffy B, Royer HD and Kassack
MU: Acquired cisplatin resistance in the head-neck cancer cell line
Cal27 is associated with decreased DKK1 expression and can
partially be reversed by overexpression of DKK1. Int J Cancer.
123:2013–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang LC, Hsieh MT, Yang JS, Lu CC, Tsai
FJ, Tsao JW, Chiu YJ, Kuo SC and Lee KH: Effect of
bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell
cycle arrest, apoptotic and autophagic pathway in triple-negative
breast adenocarcinoma MDA-MB-231 cells: An in vitro study. Int J
Oncol. 52:67–76. 2018.PubMed/NCBI
|
|
29
|
Lu CC, Yang JS, Chiang JH, Hour MJ, Lin
KL, Lee TH and Chung JG: Cell death caused by quinazolinone HMJ-38
challenge in oral carcinoma CAL 27 cells: dissections of
endoplasmic reticulum stress, mitochondrial dysfunction and tumor
xenografts. Biochim Biophys Acta. 1840:2310–2320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang HP, Lu CC, Chiang JH, Tsai FJ, Juan
YN, Tsao JW, Chiu HY and Yang JS: Pterostilbene modulates the
suppression of multidrug resistance protein 1 and triggers
autophagic and apoptotic mechanisms in cisplatin-resistant human
oral cancer CAR cells via AKT signaling. Int J Oncol. Mar
2–2018.(Epub ahead of print). View Article : Google Scholar :
|
|
31
|
Gelles JD and Chipuk JE: Robust
high-throughput kinetic analysis of apoptosis with real-time
high-content live-cell imaging. Cell Death Dis. 7:e24932016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiang JH, Yang JS, Lu CC, Hour MJ, Chang
SJ, Lee TH and Chung JG: Newly synthesized quinazolinone HMJ-38
suppresses angiogenetic responses and triggers human umbilical vein
endothelial cell apoptosis through p53-modulated Fas/death receptor
signaling. Toxicol Appl Pharmacol. 269:150–162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma YS, Weng SW, Lin MW, Lu CC, Chiang JH,
Yang JS, Lai KC, Lin JP, Tang NY, Lin JG, et al: Antitumor effects
of emodin on LS1034 human colon cancer cells in vitro and in vivo:
Roles of apoptotic cell death and LS1034 tumor xenografts model.
Food Chem Toxicol. 50:1271–1278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS,
Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration
and invasion of human colon cancer HT29 cells by inhibiting matrix
metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC
and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu SH, Hang LW, Yang JS, Chen HY, Lin HY,
Chiang JH, Lu CC, Yang JL, Lai TY, Ko YC and Chung JG: Curcumin
induces apoptosis in human non-small cell lung cancer NCI-H460
cells through ER stress and caspase cascade- and
mitochondria-dependent pathways. Anticancer Res. 30:2125–2133.
2010.PubMed/NCBI
|
|
36
|
Lu CC, Yang JS, Chiang JH, Hour MJ, Lin
KL, Lin JJ, Huang WW, Tsuzuki M, Lee TH and Chung JG: Novel
quinazolinone MJ-29 triggers endoplasmic reticulum stress and
intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits
leukemic mice. PLoS One. 7:e368312012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Glick JH, Zehngebot LM and Taylor SG IV:
Chemotherapy for squamous cell carcinoma of the head and neck: A
progress report. Am J Otolaryngol. 1:306–323. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao Y and Liu D: The roles of excision
repair cross-complementation group1 in objective response after
cisplatin-based concurrent chemoradiotherapy and survival in head
and neck cancers: A systematic review and meta-analysis. Oral
Oncol. 51:570–577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chiu YJ, Yang JS, Hsu HS, Tsai CH and Ma
H: Adipose-derived stem cell conditioned medium attenuates
cisplatin-triggered apoptosis in tongue squamous cell carcinoma.
Oncol Rep. 39:651–658. 2018.PubMed/NCBI
|
|
41
|
Hsieh MT, Chen HP, Lu CC, Chiang JH, Wu
TS, Kuo DH, Huang LJ, Kuo SC and Yang JS: The novel pterostilbene
derivative ANK-199 induces autophagic cell death through regulating
PI3 kinase class III/beclin 1/Atg-related proteins in
cisplatin-resistant CAR human oral cancer cells. Int J Oncol.
45:782–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu Z, Du S, Ding F, Guo S, Ying G and Yan
Z: Ursolic acid attenuates temozolomide resistance in glioblastoma
cells by downregulating O6-methylguanine-DNA methyltransferase
(MGMT) expression. Am J Transl Res. 8:3299–3308. 2016.PubMed/NCBI
|
|
43
|
Li J, Liang X and Yang X: Ursolic acid
inhibits growth and induces apoptosis in gemcitabine-resistant
human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
Oncol Rep. 28:501–510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shan JZ, Xuan YY, Ruan SQ and Sun M:
Proliferation-inhibiting and apoptosis-inducing effects of ursolic
acid and oleanolic acid on multi-drug resistance cancer cells in
vitro. Chin J Integr Med. 17:607–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang L, Liu X, Lu Z, Yuet-Wa Chan J, Zhou
L, Fung KP, Wu P and Wu S: Ursolic acid induces
doxorubicin-resistant HepG2 cell death via the release of
apoptosis-inducing factor. Cancer Lett. 298:128–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang J, Liu L, Qiu H, Zhang X, Guo W, Chen
W, Tian Y, Fu L, Shi D, Cheng J, et al: Ursolic acid simultaneously
targets multiple signaling pathways to suppress proliferation and
induce apoptosis in colon cancer cells. PLoS One. 8:e638722013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao N, Cheng S, Budhraja A, Gao Z, Chen J,
Liu EH, Huang C, Chen D, Yang Z, Liu Q, et al: Ursolic acid induces
apoptosis in human leukaemia cells and exhibits anti-leukaemic
activity in nude mice through the PKB pathway. Br J Pharmacol.
165:1813–1826. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang G, Yang T, Zhang W, Lu M, Ma X and
Xiang G: In vitro and in vivo antitumor effects of folate-targeted
ursolic acid stealth liposome. J Agric Food Chem. 62:2207–2215.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Subbaramaiah K, Michaluart P, Sporn MB and
Dannenberg AJ: Ursolic acid inhibits cyclooxygenase-2 transcription
in human mammary epithelial cells. Cancer Res. 60:2399–2404.
2000.PubMed/NCBI
|
|
50
|
Bui NL, Pandey V, Zhu T, Ma L and Lobie
PE: Bad phosphorylation as a target of inhibition in oncology.
Cancer Lett. 415:177–186. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cook SJ, Stuart K, Gilley R and Sale MJ:
Control of cell death and mitochondrial fission by ERK1/2 MAP
kinase signalling. FEBS J. 284:4177–4195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Datta SR, Dudek H, Tao X, Masters S, Fu H,
Gotoh Y and Greenberg ME: Akt phosphorylation of BAD couples
survival signals to the cell-intrinsic death machinery. Cell.
91:231–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pareja F, Macleod D, Shu C, Crary JF,
Canoll PD, Ross AH and Siegelin MD: PI3K and Bcl-2 inhibition
primes glioblastoma cells to apoptosis through downregulation of
Mcl-1 and Phospho-BAD. Mol Cancer Res. 12:987–1001. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pereira JK, Machado-Neto JA, Lopes MR,
Morini BC, Traina F, Costa FF, Saad ST and Favaro P: Molecular
effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120
on T and B-cell acute lymphoblastic leukaemia. Eur J Cancer.
51:2076–2085. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lin Z, Jiang J and Liu XS: Ursolic
acid-mediated apoptosis of K562 cells involves Stat5/Akt pathway
inhibition through the induction of Gfi-1. Sci Rep. 6:333582016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wu B, Wang X, Chi ZF, Hu R, Zhang R, Yang
W and Liu ZG: Ursolic acid-induced apoptosis in K562 cells
involving upregulation of PTEN gene expression and inactivation of
the PI3K/Akt pathway. Arch Pharm Res. 35:543–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lin J, Chen Y, Wei L, Shen A, Sferra TJ,
Hong Z and Peng J: Ursolic acid promotes colorectal cancer cell
apoptosis and inhibits cell proliferation via modulation of
multiple signaling pathways. Int J Oncol. 43:1235–1243. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gai L, Cai N, Wang L, Xu X and Kong X:
Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression
in T24 human bladder cancer cells. Mol Med Rep. 7:1673–1677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang Y, Kong C, Zeng Y, Wang L, Li Z,
Wang H, Xu C and Sun Y: Ursolic acid induces PC-3 cell apoptosis
via activation of JNK and inhibition of Akt pathways in vitro. Mol
Carcinog. 49:374–385. 2010.PubMed/NCBI
|
|
60
|
Meng Y, Lin ZM, Ge N, Zhang DL, Huang J
and Kong F: Ursolic acid induces apoptosis of prostate cancer cells
via the PI3K/Akt/mTOR pathway. Am J Chin Med. 43:1471–1486. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chuang WL, Lin PY, Lin HC and Chen YL: The
apoptotic effect of ursolic acid on SK-Hep-1 cells is regulated by
the PI3K/Akt, p38 and JNK MAPK signaling pathways. Molecules.
21:4602016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Son HS, Kwon HY, Sohn EJ, Lee JH, Woo HJ,
Yun M, Kim SH and Kim YC: Activation of AMP-activated protein
kinase and phosphorylation of glycogen synthase kinase3 β mediate
ursolic acid induced apoptosis in HepG2 liver cancer cells.
Phytother Res. 27:1714–1722. 2013. View Article : Google Scholar : PubMed/NCBI
|
